A TYK2 single-nucleotide polymorphism (SNP) in the kinase domain (P1104A) has been associated with different types of tumours [20] and has been found in about 7% of acute myeloid leukaemia (AML) patients [21]. This evidence concerns the gene TYK2 and acute myeloid leukemia.